CIK: 1920738 - Address: C/O 4D Molecular Therapeutics, Inc., 5858 Horton Street #455, Emeryville, CA 94608
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/18/24 20:48
4/16/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d137.60022D
4/18/24 20:48
4/16/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-4525.740-2-502D
4/3/24 19:18
4/1/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d10212.54082D
4/3/24 19:18
4/1/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-25931.780-8-822D
3/29/24 16:52
3/27/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d15225.98062D
3/29/24 16:52
3/27/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-20435.040-6-772D
3/20/24 16:40
3/18/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d137.60022D
3/20/24 16:40
3/18/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-5531.270-2-502D
2/29/24 18:01
2/27/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d3920.24022D
2/29/24 18:01
2/27/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-5730.000-2-522D
2/21/24 17:41
2/16/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d137.60022D
2/21/24 17:41
2/16/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-4827.670-2-502D
2/12/24 21:04
2/8/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCM.d6410.18062D
2/12/24 21:04
2/8/24
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOGCS.d-17227.500-6-782D
6/12/23 18:23
6/8/23
FMDT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeM.d308.04042D
6/12/23 18:23
6/8/23
FMDT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeS.d-7820.850-4-682D
6/6/23 19:23
6/1/23
FMDT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeM.d126.49022D
6/6/23 19:23
6/1/23
FMDT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeS.d-4118.310-2-562D
4/25/23 18:44
4/21/23
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeM.d308.04042D
4/25/23 18:44
4/21/23
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeS.d-7520.000-4-642D
3/3/23 18:16
3/1/23
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeM.d126.49028012D
3/3/23 18:16
3/1/23
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeS.d-4319.300-2-522D
12/5/22 17:33
12/1/22
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeM.d427.52062D
12/5/22 17:33
12/1/22
FDMT4D Molecular Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagBizily ScottCAOChief LeS.d-13722.790-6-712D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact